menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Benefits of TZDs for Early Type 2 Diabetes

ReachMD Healthcare Image
Restart
Resume
Read full article
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Where do thiazolidinediones, or TZD's, fit in our clinical approach to treating patients with type 2 diabetes? TZD's used early in the course of the disease seem to be a powerful therapy with a substantial reduction in the progression of type 2 diabetes. What does this tell us about the pathogenesis of diabetes? Join host Dr. Steven Edelman and his guest, professor of medicine and chief of the division of endocrinology, diabetes and metabolism of the University of Vermont, Dr. Jack Leahy, as they discuss the pathogenesis of diabetes and the role of thiazolidinediones in the prevention and treatment of type 2 diabetes.

     

     

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Where do thiazolidinediones, or TZD's, fit in our clinical approach to treating patients with type 2 diabetes? TZD's used early in the course of the disease seem to be a powerful therapy with a substantial reduction in the progression of type 2 diabetes. What does this tell us about the pathogenesis of diabetes? Join host Dr. Steven Edelman and his guest, professor of medicine and chief of the division of endocrinology, diabetes and metabolism of the University of Vermont, Dr. Jack Leahy, as they discuss the pathogenesis of diabetes and the role of thiazolidinediones in the prevention and treatment of type 2 diabetes.

     

     

Facebook Comments

Schedule2 Dec 2021
Webpack App